Evidence-based renal protection in cardiac surgery

Seminars in Cardiothoracic and Vascular Anesthesia

Volumn 9, Issue 1, 2005, Pages 65-76

  Stafford Smith, Mark ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ACETYLSALICYLIC ACID; ADENOSINE; ADENOSINE A1 RECEPTOR; ANARITIDE; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ATRIAL NATRIURETIC FACTOR; BUMETANIDE; CAPTOPRIL; CLONIDINE; CREATININE; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOPAMINE; ENALAPRILAT; FENOLDOPAM MESILATE; FUROSEMIDE; GLUCOSE; HYDROCHLOROTHIAZIDE; INTERLEUKIN 6; IOHEXOL; LITHIUM; LOOP DIURETIC AGENT; MANNITOL; METOLAZONE; NITRIC OXIDE; OMAPATRILAT; PROSTACYCLIN; THEOPHYLLINE; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG;

ATHEROSCLEROSIS; CARDIOPULMONARY BYPASS; DIALYSIS; EMBOLISM; EVIDENCE BASED MEDICINE; HEART ARRHYTHMIA; HEART SURGERY; HEMODILUTION; HUMAN; INFLAMMATION; ISCHEMIA; KIDNEY CIRCULATION; KIDNEY DYSFUNCTION; KIDNEY ISCHEMIA; KIDNEY TUBULE ABSORPTION; NEPHROTOXICITY; OXYGEN DIFFUSION; PERIOPERATIVE PERIOD; RENAL PROTECTION; REPERFUSION; REVIEW; RISK ASSESSMENT; RISK FACTOR; SIDE EFFECT; TREATMENT PLANNING;

CARDIAC SURGICAL PROCEDURES; EVIDENCE-BASED MEDICINE; HUMANS; KIDNEY DISEASES; POSTOPERATIVE COMPLICATIONS;

EID: 14744267447     PISSN: 10892532     EISSN: None     Source Type: Journal    
DOI: 10.1177/108925320500900107     Document Type: Review

References (122)

1. Doberneck R, Reiser M, Lillehei C: Acute renal failure after open-heart surgery utilizing extracorporeal circulation and total body perfusion. J Thor Cardiovasc Surg 43:441-452, 1962.
2. Chertow GM, Levy EM, Hammermeister KE, et al: Independent association between acute renal failure and mortality following cardiac surgery. Am J Med 104:343-348, 1998.
3. Conlon PJ, Stafford-Smith M, White WD, et al: Acute renal failure following cardiac surgery. Nephrol Dial Transplant 14:1158-1162, 1999.
4. Mora-Mangano C, Diamondstone LS, Ramsay JG, et al: Renal dysfunction after myocardial revascularization: Risk factors, adverse outcomes, and hospital resource utilization. The Multicenter Study of Perioperative Ischemia Research Group. Ann Intern Med 128:194-203, 1998.
5. Page US, Washburn T: Using tracking data to find complications that physicians miss: The case of renal failure in cardiac surgery. Jt Comm J Qual Improv 23:511-520, 1997.
6. Mora-Mangano C, Boisvert D, Zhou S, et al: Small reductions in renal function following CABG independently predict hospitalization. Anesth Analg 90:SCA 35, 2000.
7. Stafford-Smith M, Phillips-Bute B, Reddan D, et al: The association of postoperative peak and fractional change in serum creatinine with mortality after coronary bypass surgery. Anesthesiology 93:A240, 2000.
8. Mazzarella V, Gallucci MT, Tozzo C, et al: Renal function in patients undergoing cardiopulmonary bypass operations. J Thorac Cardiovasc Surg 104:1625-1627, 1992.
9. Kelly KJ: Distant effects of experimental renal ischemia/reperfusion injury. J Am Soc Nephrol 14:1549-1558, 2003.
10. Smith H: In: Lawrence K, ed. Lectures on the Kidney: University of Kansas; 1943:3.
11. Rabb H, Wang Z, Nemoto T, et al: Acute renal failure leads to dysregulation of lung salt and water channels. Kidney Int 63:600-606, 2003.
12. Stafford-Smith M: Chapter 5: Perioperative renal dysfunction: Implications and strategies for protection. In: Newman MF, ed. 2003 Society of Cardiovascular Anesthesiologists Monograph-Perioperative Organ Protection: Lippincott Williams & Wilkins; 2003:89-124.
13. Brezis M, Rosen S: Hypoxia of the renal medulla - its implications for disease. N Engl J Med 332:647-655, 1995.
14. Navar LG, Inscho EW, Majid SA, et al: Paracrine regulation of the renal microcirculation. Physiol Rev 76:425-536, 1996.
15. Andersson LG, Bratteby LE, Ekroth R, et al: Renal function during cardiopulmonary bypass: Influence of pump flow and systemic blood pressure. Eur J Cardiothorac Surg 8:597-602, 1994.
16. Davila-Roman VG, Kouchoukos NT, Schechtman KB, et al: Atherosclerosis of the ascending aorta is a predictor of renal dysfunction after cardiac operations. J Thorac Cardiovasc Surg 117:111-116, 1999.
17. Cunningham PN, Dyanov HM, Park P, et al: Acute renal failure in endotoxemia is caused by TNF acting directly on TNF receptor-1 in kidney. J Immunol 168:5817-5823, 2002.
18. Segerer S, Nelson PJ, Schlondorff D: Chemokines, chemokine receptors, and renal disease: From basic science to pathophysiologic and therapeutic studies. J Am Soc Nephrol 11:152-176, 2000.
19. Heyman SN, Darmon D, Goldfarb M, et al: Endotoxin-induced renal failure. I. A role for altered renal microcirculation. Exp Nephrol 8:266-274, 2000.
20. Myers B, Moran S: Hemodynamically mediated acute renal failure. N Engl J Med 314:97-105, 1986.
21. Chertow GM, Lazarus JM, Christiansen CL, et al: Preoperative renal risk stratification. Circulation 95:878-884, 1997.
22. Zanardo G, Michielon P, Paccagnella A, et al: Acute renal failure in the patient undergoing cardiac operation. Prevalence, mortality rate, and main risk factors. J Thorac Cardiovasc Surg 107:1489-1495, 1994.
23. Yeh T, Brackney E, Hall D, Ellison R: Renal complications of open-heart surgery: Predisposing factors, prevention and management. J Thor Cardiovasc Surg 47:79-95, 1964.
24. Porter GA, Kloster FE, Herr RJ, et al: Renal complications associated with valve replacement surgery. J Thorac Cardiovasc Surg 53:145-152, 1967.
25. McLeish KR, Luft FC, Kleit SA. Factors affecting prognosis in acute renal failure following cardiac operations. Surg Gynecol Obstet 145:28-32, 1977.
26. Mangos GJ, Brown MA, Chan WY, et al: Acute renal failure following cardiac surgery: Incidence, outcomes and risk factors. Aust N Z J Med 25:284-289, 1995.
27. Llopart T, Lombardi R, Forselledo M, et al: Acute renal failure in open heart surgery. Ren Fail 19:319-323, 1997.
28. Hilberman M, Myers BD, Carrie BJ, et al: Acute renal failure following cardiac surgery. J Thorac Cardiovasc Surg 77:880-888, 1979.
29. Heikkinen L, Harjula A, Merikallio E: Acute renal failure related to open-heart surgery. Ann Chir Gynaecol 74:203-209, 1985.
30. Gailiunas P Jr, Chawla R, Lazarus JM, et al: Acute renal failure following cardiac operations. J Thorac Cardiovasc Surg 79:241-243, 1980.
31. Corwin HL, Sprague SM, DeLaria GA, et al: Acute renal failure associated with cardiac operations. A case-control study. J Thorac Cardiovasc Surg 98:1107-1112, 1989.
32. Bhat JG, Gluck MC, Lowenstein J, et al: Renal failure after open heart surgery. Ann Intern Med 84:677-682, 1976.
33. Andersson LG, Ekroth R, Bratteby LE, et al: Acute renal failure after coronary surgery - a study of incidence and risk factors in 2009 consecutive patients. Thorac Cardiovasc Surg 41:237-241, 1993.
34. Abel RM, Buckley MJ, Austen WG, et al: Etiology, incidence, and prognosis of renal failure following cardiac operations. Results of a prospective analysis of 500 consecutive patients. J Thorac Cardiovasc Surg 71:323-333, 1976.
35. Stafford Smith M, Conlon P, White W, et al: Low hematocrit but not perfusion pressure during CPB is predictive for renal failure following CABG surgery. Anesth Analg 86:SCA102, 1998.
36. Ostermann ME, Taube D, Morgan CJ, et al: Acute renal failure following cardiopulmonary bypass: A changing picture. Intensive Care Med 26:565-571, 2000.
37. Swaminathan M, Phillips-Bute BG, Conlon PJ, et al: The association of lowest hematocrit during cardiopulmonary bypass with acute renal injury after coronary bypass surgery. Ann Thorac Surg 76:784-791, 2003.
38. Mora-Mangano C, Diamondstone LS, Ramsay JG, et al: Renal dysfunction after myocardial revascularization: Risk factors, adverse outcomes, and hospital resource utilization. The Multicenter Study of Perioperative Ischemia Research Group. Ann Intern Med 128:194-203, 1998.
39. Rao V, Weisel RD, Buth KJ, et al: Coronary artery bypass grafting in patients with non-dialysis-dependent renal insufficiency. Circulation 96:II-38-43, 1997.
40. Anderson RJ, O'Brien M, MaWhinney S, et al: Mild renal failure is associated with adverse outcome after cardiac valve surgery. Am J Kidney Dis 35:1127-1134, 2000.
41. Anderson RJ, O'Brien M, MaWhinney S, et al: Renal failure predisposes patients to adverse outcome after coronary artery bypass surgery. VA Cooperative Study #5. Kidney Int 55:1057-1062, 1999.
42. Chew ST, Newman MF, White WD, et al: Preliminary report on the association of apolipoprotein E polymorphisms, with postoperative peak serum creatinine concentrations in cardiac surgical patients. Anesthesiology 93:325-331, 2000.
43. Gaudino M, Di Castelnuovo A, Zamparelli R, et al: Genetic control of postoperative systemic inflammatory reaction and pulmonary and renal complications after coronary artery surgery. J Thorac Cardiovasc Surg 126:1107-1112, 2003.
44. Fischer UM, Weissenberger WK, Warters RD, et al: Impact of cardiopulmonary bypass management on postcardiac surgery renal function. Perfusion 17:401-406, 2002.
45. Gamoso MG, Phillips-Bute B, Landolfo KP, et al: Off-pump versus on-pump coronary artery bypass surgery and postoperative renal dysfunction. Anesth Analg 91:1080-1084, 2000.
46. Fischer S, Phillips-Bute B, Stafford-Smith M: Does off-pump coronary artery bypass surgery with a connector device reduce postoperative renal dysfunction? Anesth Analg 98:SCA45, 2004.
47. McCreath BJ, Swaminathan M, Booth JV, et al: Mitral valve surgery and acute renal injury: Port access versus median sternotomy. Ann Thorac Surg 75:812-819, 2003.
48. Suen WS, Mok CK, Chiu SW, et al: Risk factors for development of acute renal failure (ARF) requiring dialysis in patients undergoing cardiac surgery. Angiology 49:789-800, 1998.
49. Urzua J, Troncoso S, Bugedo G, et al: Renal function and cardiopulmonary bypass: Effect of perfusion pressure. J Cardiothorac Vasc Anesth 6:299-303, 1992.
50. Wang MJ, Chen TL, Fan SZ, et al: Change of blood pressure and urine flow rate during cardiopulmonary bypass and its relation to postoperative renal function. J Formos Med Assoc 93:222-226, 1994.
51. East C, Reves J, Phillips-Bute B, et al: Acute renal dysfunction following cardiac surgery: Influence of temperature during CPB. Anesth Analg 88:SCA32, 1999.
52. Ip-Yam PC, Murphy S, Baines M, et al: Renal function and proteinuria after cardiopulmonary bypass: The effects of temperature and mannitol. Anesth Analg 78:842-847, 1994.
53. Swaminathan M, East C, Phillips-Bute B, et al: Report of a substudy on warm versus cold cardiopulmonary bypass: Changes in creatinine clearance. Ann Thorac Surg 72:1603-1609, 2001.
54. Conger JD. Interventions in clinical acute renal failure: what are the data? Am J Kidney Dis 26:565-576, 1995.
55. Vijayan A, Miller SB. Acute renal failure: Prevention and nondialytic therapy. Semin Nephrol 18:523-532, 1998.
56. Galley HF. Renal-dose dopamine: Will the message now get through? Lancet 356:2112-2113, 2000.
57. Bellomo R, Chapman M, Finfer S, et al: Low-dose dopamine in patients with early renal dysfunction: A placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. Lancet 356:2139-2143, 2000.
58. Korner A, Eklof AC, Celsi G, et al: Increased renal metabolism in diabetes. Mechanism and functional implications. Diabetes 43:629-633, 1994.
59. Stafford-Smith M, Phillips-Bute B, Reddan DN, et al: The association of epsilon-aminocaproic acid with postoperative decrease in creatinine clearance in 1502 coronary bypass patients. Anesth Analg 91:1085-1090, 2000.
60. Stafford-Smith M: Antifibrinolytic agents make alpha1-and beta2-microglobulinuria poor markers of postcardiac surgery renal dysfunction. Anesthesiology 90:928-929, 1999.
61. Domart Y, Trouillet JL, Fagon JY, et al: Incidence and morbidity of cytomegaloviral infection in patients with mediastinitis following cardiac surgery. Chest 97:18-22, 1990.
62. Marik PE: Low-dose dopamine: A systematic review. Intensive Care Med 28:877-883, 2002.
63. Kellum JA, Decker JM: Use of dopamine in acute renal failure: A meta-analysis. Crit Care Med 29:1526-1531, 2001.
64. Prins I, Plotz FB, Uiterwaal CS, et al: Low-dose dopamine in neonatal and pediatric intensive care: A systematic review. Intensive Care Med 27:206-210, 2001.
65. Duke GJ, Bersten AD. Dopamine and renal salvage in the critically ill patient. Anaesth Intensive Care 20:277-287, 1992.
66. Jakob SM, Ruokonen E, Takala J: Effects of dopamine on systemic and regional blood flow and metabolism in septic and cardiac surgery patients. Shock 18:8-13, 2002.
67. Hoffman TM, Bush DM, Wernovsky G, et al: Postoperative junctional ectopic tachycardia in children: Incidence, risk factors, and treatment. Ann Thorac Surg 74:1607-1611, 2002.
68. Stone GW, McCullough PA, Tumlin JA, et al: Fenoldopam mesylate for the prevention of contrast-induced nephropathy: A randomized controlled trial. JAMA 290:2284-2291, 2003.
69. Shorten G: Fenoldopam: Potential clinical applications in heart surgery. Rev Esp Anestesiol Reanim 48:487-491, 2001.
70. Caimmi PP, Pagani L, Micalizzi E, et al: Fenoldopam for renal protection in patients undergoing cardiopulmonary bypass. J Cardiothorac Vasc Anesth 17:491-494, 2003.
71. Tumlin J, Finckle K, Murray P, et al: Dopamine receptor 1 agonists in early acute tubular necrosis: A prospective, randomized, double blind, placebo-controlled trial of fenoldopam mesylate. J Am Soc Nephrol 14:PUB001, 2003.
72. Brezis M, Agmon Y, Epstein FH. Determinants of intrarenal oxygenation. I. Effects of diuretics. Am J Physiol 267:F1059-1062, 1994.
73. Liss P: Effects of contrast media on renal microcirculation and oxygen tension. An experimental study in the rat. Acta Radiol Suppl 409:1-29, 1997.
74. Lindner A, Cutler R, Goodman W: Synergism of dopamine plus furosemide in preventing acute renal failure in the dog. Kidney Int 16:158-166, 1979.
75. Heyman SN, Rosen S, Epstein FH, et al: Loop diuretics reduce hypoxic damage to proximal tubules of the isolated perfused rat kidney. Kidney Int 45:981-985, 1994.
76. Hager B, Betschart M, Krapf R: Effect of postoperative intravenous loop diuretic on renal function after major surgery. Schweiz Med Wochenschr 126:666-673, 1996.
77. Shilliday IR, Quinn KJ, Allison ME. Loop diuretics in the management of acute renal failure: A prospective, double-blind, placebo-controlled, randomized study. Nephrol Dial Transplant 12:2592-2596, 1997.
78. Nuutinen L, Hollmen A: The effect of prophylactic use of furosemide on renal function during open heart surgery. Ann Chir Gynaecol 65:258-266, 1976.
79. Charlson M, Krieger KH, Peterson JC, et al: Predictors and outcomes of cardiac complications following elective coronary bypass grafting. Proc Assoc Am Physicians 111:622-632, 1999.
80. Lassnigg A, Donner E, Grubhofer G, et al: Lack of renoprotective effects of dopamine and furosemide during cardiac surgery. J Am Soc Nephrol 11:97-104, 2000.
81. Mehta R, Pascual M, Soroko S, et al PICARD Study Group: Diuretics, mortality, and nonrecovery of renal function in acute renal failure. JAMA 288:2547-2553, 2002.
82. Albright RC Jr. Acute renal failure: A practical update. Mayo Clin Proc 76:67-74, 2001.
83. Blantz RC, Weir MR. Are the oxygen costs of kidney function highly regulated? Curr Opin Nephrol Hypertens 13:67-71, 2004.
84. Fisher AR, Jones P, Barlow P, et al: The influence of mannitol on renal function during and after open-heart surgery. Perfusion 13:181-186, 1998.
85. Nishimura O, Tokutsu S, Sakurai T, et al: Effects of hypertonic mannitol on renal function in open heart surgery. Jpn Heart J 24:245-257, 1983.
86. Pass LJ, Eberhart RC, Brown JC, et al: The effect of mannitol and dopamine on the renal response to thoracic aortic cross-clamping. J Thorac Cardiovasc Surg 95:608-612, 1988.
87. Visweswaran P, Massin EK, Dubose TD Jr: Mannitol-induced acute renal failure. J Am Soc Nephrol 8:1028-1033, 1997.
88. Gubern JM, Sancho JJ, Simo J, et al: A randomized trial on the effect of mannitol on postoperative renal function in patients with obstructive jaundice. Surgery 103:39-44, 1988.
89. Meyer M, Wiebe K, Wahlers T, et al: Urodilatin (INN:ularitide) as a new drug for the therapy of acute renal failure following cardiac surgery. Clin Exp Pharmacol Physiol 24:374-376, 1997.
90. Brenner P, Meyer M, Reichenspurner H, et al: Significance of prophylactic urodilatin (INN: ularitide) infusion for the prevention of acute renal failure in patients after heart transplantation. Eur J Med Res 1:137-143, 1995.
91. Allgren RL, Marbury TC, Rahman SN, et al: Anaritide in acute tubular necrosis. Auriculin Anaritide Acute Renal Failure Study Group. N Engl J Med 336:828-834, 1997.
92. Lewis J, Salem MM, Chertow GM, et al: Atrial natriuretic factor in oliguric acute renal failure. Anaritide Acute Renal Failure Study Group. Am J Kidney Dis 36:767-774, 2000.
93. Lee HT, Emala CW. Protective effects of renal ischemic preconditioning and adenosine pretreatment: role of A(1) and A(3) receptors. Am J Physiol Renal Physiol 278:F380-387, 2000.
94. Lee HT, Gallos G, Nasr SH, et al: A(1) adenosine receptor activation inhibits inflammation, necrosis, and apoptosis after renal ischemia-reperfusion injury in mice. J Am Soc Nephrol 15:102-111, 2004.
95. Modlinger PS, Welch WJ. Adenosine A1 receptor antagonists and the kidney. Curr Opin Nephrol Hypertens 12:497-502, 2003.
96. Mangano DT. Aspirin and mortality from coronary bypass surgery. N Engl J Med 347:1309-1317, 2002.
97. Zhou X, Ono H, Ono Y, et al: Renoprotective effects of omapatrilat are mediated partially by bradykinin. Am J Nephrol 23:214-221, 2003.
98. Kostis JB, Packer M, Black HR, et al: Omapatrilat and enalapril in patients with hypertension: The Omapatrilat Cardiovascular Treatment vs. Enalapril (OCTAVE) trial. Am J Hypertens 17:103-111, 2004.
99. Kshirsagar AV, Poole C, Mottl A, et al: N-acetylcysteine for the prevention of radiocontrast induced nephropathy: A meta-analysis of prospective controlled trials. J Am Soc Nephrol 15:761-769, 2004.
100. Pannu N, Manns B, Lee HH, et al: Systematic review of the impact of N-acetylcysteine on contrast nephropathy. Kidney Int 65:1366-1374, 2004.
101. Alonso A, Lau J, Jaber BL, et al: Prevention of radiocontrast nephropathy with N-acetylcysteine in patients with chronic kidney disease: A meta-analysis of randomized, controlled trials. Am J Kidney Dis 43:1-9, 2004.
102. Hoffmann U, Fischereder M, Kruger B, et al: The value of N-acetylcysteine in the prevention of radiocontrast agent-induced nephropathy seems questionable. J Am Soc Nephrol 15:407-410, 2004.
103. Kretzschmar M, Klein U, Palutke M, et al: Reduction of ischemia-reperfusion syndrome after abdominal aortic aneurysmectomy by N-acetylcysteine but not mannitol. Acta Anaesthesiol Scand 40:657-664, 1996.
104. Cote G, Denault A, Belisle S, et al: N-acetylcysteine in the preservation of renal function in patients undergoing cardiac surgery. Anesthesiology 99:A420, 2003.
105. Solez K, Ideura T, Silvia CB, et al: Clonidine after renal ischemia to lessen acute renal failure and microvascular damage. Kidney Int 18:309-322, 1980.
106. Ideura T, Solez K, Heptinstall RH. The effect of clonidine on tubular obstruction in postischemic acute renal failure in the rabbit demonstrated by microradiography and microdissection. Am J Pathol 98:123-150, 1980.
107. Eknoyan G, Dobyan DC, Senekjian HO, et al: Protective effect of oral clonidine in the prophylaxis and therapy of mercuric chloride-induced acute renal failure in the rat. J Lab Clin Med 102:699-713, 1983.
108. Eknoyan G, Bulger RE, Dobyan DC. Mercuric chloride-induced acute renal failure in the rat. I. Correlation of functional and morphologic changes and their modification by clonidine. Lab Invest 46:613-620, 1982.
109. Zou AP, Cowley AW Jr: α(2)-Adrenergic receptor-mediated increase in NO production buffers renal medullary vasoconstriction. Am J Physiol Regul Integr Comp Physiol 279:R769-777, 2000.
110. Kulka PJ, Tryba M, Zenz M: Preoperative alpha2-adrenergic receptor agonists prevent the deterioration of renal function after cardiac surgery: results of a randomized, controlled trial. Crit Care Med 24:947-952, 1996.
111. Myles PS, Hunt JO, Holdgaard HO, et al: Clonidine and cardiac surgery: Haemodynamic and metabolic effects, myocardial ischaemia and recovery. Anaesth Intensive Care 27:137-147, 1999.
112. Schramm L, Heidbreder E, Kartenbender K, et al: Effects of urodilatin and diltiazem on renal function in ischemic acute renal failure in the rat. Am J Nephrol 15:418-426, 1995.
113. Schramm L, Heidbreder E, Lukes M, et al: Endotoxin-induced acute renal failure in the rat: Effects of urodilatin and diltiazem on renal function. Clin Nephrol 46:117-124, 1996.
114. Zanardo G, Michielon P, Rosi P, et al: Effects of a continuous diltiazem infusion on renal function during cardiac surgery. J Cardiothorac Vasc Anesth 7:711-716, 1993.
115. Bergman AS, Odar-Cederlof I, Westman L, et al: Diltiazem infusion for renal protection in cardiac surgical patients with preexisting renal dysfunction. J Cardiothorac Vasc Anesth 16:294-299, 2002.
116. Kitagawa S, Komatsu Y, Futatsuyama M, et al: Renoprotection of ace inhibitor and angiotensin II receptor blocker for the patients with severe renal insufficiency. Nephrology 8(Suppl):A26-A27, 2003.
117. Welch WJ, Wilcox CS. AT1 receptor antagonist combats oxidative stress and restores nitric oxide signaling in the SHR. Kidney Int 59:1257-1263, 2001.
118. Colson P, Ribstein J, Mimran A, et al: Effect of angiotensin converting enzyme inhibition on blood pressure and renal function during open heart surgery. Anesthesiology 72:23-27, 1990.
119. Ryckwaert F, Colson P, Ribstein J, et al: Haemodynamic and renal effects of intravenous enalaprilat during coronary artery bypass graft surgery in patients with ischaemic heart dysfunction. Br J Anaesth 86:169-175, 2001.
120. Rady MY, Ryan T: The effects of preoperative therapy with angiotensin-converting enzyme inhibitors on clinical outcome after cardiovascular surgery. Chest 114:487-494, 1998.
121. Cittanova ML, Zubicki A, Savu C, et al: The chronic inhibition of angiotensin-converting enzyme impairs postoperative renal function. Anesth Analg 93:1111-1115, 2001.
122. Rutkowski P, Tylicki L, Renke M, et al: Low-dose dual blockade of the renin-angiotensin system in patients with primary glomerulonephritis. Am J Kidney Dis 43:260-268, 2004.